Halozyme Therapeutics shares owned by Cresset Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Cresset Asset Management
from 13F filings
Historical chart of Cresset Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Cresset Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Halozyme Therapeutics by Cresset Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $11M | 281k | 40.68 |
2023-12-31 | $7.7M | 208k | 36.96 |
2023-09-30 | $6.9M | 180k | 38.20 |
2023-06-30 | $3.8M | 106k | 36.07 |